Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-953-2 | CAS number: 112-27-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An oral LD50 was determined to be > 16 mL/kg bw (18080 mg/kg bw).
The dermal LD50 for rabbits was determined to be > 16 mL/kg bw (18080 mg/kg bw).
The inhalation LC50 for rats was determined to be > 5.2 mg/L.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- Five Sprague-Dawley rats per sex per dose were exposed to the test substance via oral gavage at a dose level of 16 mL/kg bw (equivalent to 18080 mg/kg bw). After an observation period of 14 days animals were necropsied.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Batch no.: TS-3200424
- Appearance: Colorless, transparent viscous liquid
- Purity: 99.82% - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 200-300 g
- Fasting period before study: The rats are fasted overnight before dosing.
- Diet: commerical diet (ad libitum)
- Water: municipal water (ad libitum) - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- The animals receive the test material by stomach intubation with a ball-end stainless steel needle. The sample is injected trough the needle by means of a syringe and doses are varied by adjusting the volume of the test material or its dilution.
- Doses:
- 16 mL/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- 5 males and 5 females are included on each level used for the LD50 calculation. LD50 and the estimated LD50 slopes are calculated by the moving average method and are based on a 14-day observation period. Animals weights are recorded at 0 days (before dose), 7 days and 14 days (just prior to sacrifice). At death or sacrifice, each animal is subjected to gross pathologic evaluation.
- Statistics:
- no data
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 16 mL/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Equivalent to 18080 mg/kg bw
- Mortality:
- none
- Clinical signs:
- other: sluggishness, unsteady gait
- Gross pathology:
- no remarkable gross lesions
- Interpretation of results:
- GHS criteria not met
Reference
Signs of toxicity included sluggishness and an unsteady gait. Recovery occurred at 3 hours to 1 day. There were no remarkable gross lesions evident at necropsy.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 18 080 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Followed the specific protocol and standard protocol amendment by the Bushy Run Research Center. Five Sprague-Dawley rats per sex per dose were exposed to the aerolised test substance via a whole body inhalation system. They were exposed to a dose of 5.2 mg/L air for 4 hours. After an observation period of 14 days animals wer necropsied.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- traditional method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Source: Union Carbide Chemicals and Plastics Company Inc., Texas City, TX
- Purity: ≥ 99.7% - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague-Dawley Inc., Indianapolis, IN
- Housing: Rats were housed 5 per sex in stainless steel, wire-mesh cages in 2 rooms for the prestudy quarantine and postexposure periods, respectively. During exposure, rats were housed individually in 21 x 12.5 x 18 cm wire-mesh cages and exposed in a 1300-liter Plexiglas and stainless steel chamber
- Diet: Pelletal feed (Pro Lab RMH #3000, Agway, Inc.), ad libitum, except during exposure
- Water: tap water, ad libitum, except during exposure
ENVIRONMENTAL CONDITIONS
- Temperature: 19-23 °C
- Humidity: 40-56%
- Photoperiod: 12/12 h - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 5.54 µm
- Geometric standard deviation (GSD):
- 2.71
- Remark on MMAD/GSD:
- MMAD 95% confidence interval were 4.72 - 6.50 µm
- Details on inhalation exposure:
- The test substance was metered from a piston pump (Fluid Metering Inc., Oyster Bay, NY) into an atomizer (Spraying Systems Co., Wheaton, IL) fitted with a No. 1650 liquid nozzle and a No. 64 air nozzle. The atomizer was positioned in the top of the inhalation chamber turret where the liquid diluted to the desired concentration and dispersed throughout the chamber by filtered supply air.
The target concentration for the exposure was 5 mg/L, based on the guidelines for "limit" testing met forth by the Toxic Substances Control Act (TSCA). A particle size lower than an MMAD of 5.3 µm could not be produced without greatly reducing the aerosol concentration of the test substance. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 5.2 mg/L air
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Animals were observed for signs of toxic effects on the day of exposure and daily following exposure. The animals were weighed prior to exposure and postexposure Days 7 and 14. The change in body weight was calculated by subtracting the pre-exposure values from each successive weight. A complete necropsy was performed for all animals. The survivors were anaesthesized with methoxyflurane and killed by exsanguination via the brachial blood vessels. No tissues were saved.
- Statistics:
- The mean and standard deviation of the body weights, body weight changes, and exposure concentrations were calculated. No statistical comparisons were made.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.2 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortality was observed.
- Clinical signs:
- other: Periocular wetness, blepharospasm wet (oily fur), absence of toe and tail pinch reflexes. Unkempt fur was the only sign observed during the post-exposure period.
- Gross pathology:
- No macroscopic lesions were observed in animals sacrificed at the end of the 2-week post-exposure period.
- Interpretation of results:
- GHS criteria not met
Reference
A mean (+/- SD) of the test substance concentration of 5.23 (±0.15) mg/L was obtained. The nominal concentration was 19.3 mg/L.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 5 200 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- Five New Zealand White rabbits per sex per dose were received a dermal application of 16.0 mL/kg bw. This was held into place for 24 hours under occlusive dressing. After the contact period, excess fluid is removed to diminish ingestion. After an observation period of 14 days animals the LD50 was determined.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Batch no.: TS-3200424
- Appearance: Colorless, transparent viscous liquid
- Purity: 99.82% - Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 2.0-3.0 kg
- Diet: commerical diet (ad libitum)
- Water: municipal water (ad libitum) - Type of coverage:
- occlusive
- Vehicle:
- not specified
- Details on dermal exposure:
- Animals are subjected to 24 hours of contact with the test substance which is retained under impervious sheeting on the clipped, intact skin of the trunk. As necessary for larger doses, gauze is wrapped around the trunk over the sample to prevent leakage. Vetrap Bandaging Tape is wrapped over the impervious sheeting and the animal is returned to its cage for the contact period. Doses are varied by adjusting the volume or weight of the test material. Solids are dosed as powders and are moistened with a sufficient amount of water or other suitable vehicle to form a paste. After the contact period, excess fluid is removed to diminish ingestion.
- Duration of exposure:
- 24 hours
- Doses:
- 16.0 mL/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- Observations for skin reaction are made at one hour, 7 days and 14 days after the contact period. 5 males and 5 females are included on each level used for the LD50 calculation.
- Statistics:
- no data
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 16 mL/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Effect value equivalent to 18080 mg/kg bw
- Mortality:
- - males: 0/5
- females:1/5 - Clinical signs:
- other: There were no cutaneous effects observed on any animal during the observation period. The only abnormal signs noted were emaciation (in one female) and abdominal distention (in 2 females)
- Gross pathology:
- Necropsy of the animal that died revealed gas-filled intestines.
- Interpretation of results:
- GHS criteria not met
Reference
None of 5 male rabbits died from 16.0 mL/kg. One of 5 females died from this dose. There were no cutaneous effects observed on any animal during the observation period. The only abnormal signs noted were emaciation (in one female) and abdominal distention (in 2 females). One female rabbit died at 6 days. Necropsy of the animal that died revealed gas-filled intestines. The afore-mentioned signs, the one death and the necropsy findings could be attributable to a spontaneous intestinal disorder often observed in this species rather than to chemical toxicity. Gross pathologic evaluation of survivors revealed tan lungs (of one female), liquid-filled stomach and intestines (one female) and slight vascularization of the treated skin (one male).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 18 080 mg/kg bw
Additional information
An acute oral LD50 value of > 16 mL/kg bw (18080 mg/kg bw) for male and female rats was reported. Clinical signs observed were sluggishness and unsteady gait. Recovery occurred 3 hours to 1 day. There were no remarkable gross lesions evident at necropsy. No mortalities were seen (BRRC, 1990).
In a GLP-compliant acute inhalation study performed with Sprague-Dawley rats, 5 male and 5 female animals were exposed whole body to an aerosol of 5.4 mg/L. No mortalities were reported. Clinical signs found were periocular wetness, blepharospasm wet (oily) fur, absence of toe and tail pinch reflexes. Unkempt fur was the only sign observed during the post-exposure period. No macroscopic lesions were observed in animals sacrificed at the end of the 2-week post-exposure period. The acute inhalative LC50 value was found to be > 5.2 mg/L for 4 hours. (BRRC, 1991).
An acute dermal LD50 value of > 16 mL/kg bw (18080 mg/kg bw) was reported for male and female rabbits. The test substance was given to the intact skin of the trunk. One female animal died; no cutaneous effects were observed on any animal during the observation period. The only abnormal signs noted were emaciation in one female and abdominal distention in 2 females (BRRC, 1990).
Justification for classification or non-classification
The available experimental animal data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Based on the available information classification for acute toxicity is not warranted in accordance with EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation No. (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.